7 completed, 4 recruiting, 1 enrolling by invitation, 1 unknown. 8 Not applicable, 4 Phase 1, 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 4, Recruiting 2, Enrolling by invitation 1, Unknown 1 |
| Phase 1 | 4 | Completed 3, Recruiting 1 |
| Phase 2 | 4 | Completed 3, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Chronic Spinal Cord Injury: new trials by email Literature Review of Chronic Spinal Cord Injury trials Research Report on Chronic Spinal Cord Injury
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury NVG-291, Placebo - Chronic Spinal Cord Injury | Phase 3 | Recruiting | NervGen Pharma | 150 | 2026-09-28 | 2026-11-06 |
| ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury ARC-IM Therapy - Spinal Cord Injury, SCI | Not applicable | Recruiting | Ecole Polytechnique Fédérale de Lausanne | 12 | 2026-04-01 | 2026-04-21 |
| First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury STUP-001 - Spinal Cord Injury, Chronic Spinal Cord Injury | Phase 1 / Phase 2 | Recruiting | Yonsei University | 9 | 2025-07-30 | 2025-07-16 |
| Abdominal Electrical Stimulation for Bowel Dysfunction in SCI Abdominal transcutaneous electrical stimulation (TES) - Chronic Spinal Cord Injury | Not applicable | Enrolling by invitation | University of Alberta | 12 | 2025-07-14 | 2026-06-25 |
| NVG-291 in Spinal Cord Injury Subjects NVG-291, Placebo Injection - Spinal Cord Injuries, Chronic Spinal Cord Injury | Phase 1 / Phase 2 | Completed | NervGen Pharma | 24 | 2023-08-08 | 2026-11-20 |
| RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation RESToration Of Rehabilitative function with Epidural spinal Stimulation - Chronic Spinal Cord Injury | Not applicable | Recruiting | National Neuroscience Institute | 18 | 2022-12-19 | 2026-01-26 |
| LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury LIFT System - Chronic Spinal Cord Injury | Not applicable | Completed | ONWARD Medical, Inc. | 17 | 2022-03-03 | 2022-09-16 |
| The Up-LIFT Study of Non-Invasive ARC Therapy for Spinal Cord Injury LIFT System - Chronic Spinal Cord Injury | Not applicable | Completed | ONWARD Medical, Inc. | 65 | 2021-01-08 | 2022-09-16 |
| Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation High Dose, Low dose - Chronic Spinal Cord Injury, Neurogenic Bladder | Not applicable | Completed | The University of Texas Health Science Center, Houston | 50 | 2019-11-19 | 2024-10-15 |
| AXER-204 in Participants With Chronic Spinal Cord Injury AXER-204, Placebo - Chronic Spinal Cord Injury | Phase 1 / Phase 2 | Completed | ReNetX Bio, Inc. | 52 | 2019-07-16 | 2023-08-22 |
| Home Neuromodulation of the Neurogenic Bladder in Chronic Spinal Cord Injury With Transcutaneous Tibial Nerve Stimulation 4-week TTNS home-based protocol - Chronic Spinal Cord Injury, Neurogenic Bowel | Not applicable | Completed | The University of Texas Health Science Center, Houston | 16 | 2018-03-13 | 2021-10-29 |
| Impact of Persistent Conductances on Motor Unit Firing in SCI sugar pill, Riluzole, Isradipine - Chronic Spinal Cord Injury | Not applicable | Unknown | Shirley Ryan AbilityLab | 50 | 2009-06-01 | 2014-05-13 |
| Cell Transplant in Spinal Cord Injury Patients Autologous bone marrow transplant, Physical therapy - Chronic Spinal Cord Injury | Phase 1 / Phase 2 | Completed | Cairo University | 80 | 2005-05-01 | 2009-01-05 |
Spinal Cord Injuries (7) · Quadriplegia (3) · Intestinal Diseases (1) · Neurogenic Bowel (1) · Urinary Bladder, Neurogenic (1)
Nervous System Diseases (11) · Central Nervous System Diseases (7) · Spinal Cord Diseases (7) · Trauma, Nervous System (7) · Wounds and Injuries (7) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Paralysis (3) · Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Colonic Diseases (1) · Colonic Diseases, Functional (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Isradipine (1) · Memantine (1) · Physical Therapy Modalities (1) · Riluzole (1) · Sugars (1)
NervGen Pharma (2) · ONWARD Medical, Inc. (2) · The University of Texas Health Science Center, Houston (2) · Cairo University (1) · Ecole Polytechnique Fédérale de Lausanne (1) · National Neuroscience Institute (1) · ReNetX Bio, Inc. (1) · Shirley Ryan AbilityLab (1) · University of Alberta (1) · Yonsei University (1)
United States (7) · Canada (3) · Egypt (1) · Netherlands (1) · Singapore (1) · South Korea (1) · Switzerland (1) · United Kingdom (1)
Argyos Stampas, MD (1) · Argyrios Stampas, MD (1) · Candace Tefertiller, PT, DPT, PhD, NCS (1) · Chester Ho, MD (1) · Chet Moritz, PhD (1) · Edelle Field-Fote, PT, PhD (1) · George Maynard, PhD (1) · Jocelyne Bloch, Prof. Dr. MD (1) · Randall Kaye, M.D. (1)
PMID 23452836, PMID 37479373, PMID 38769431, PMID 39093916, PMID 40568376, PMID 40744729, PMID 41019097
KL2TR003168 (1)